Novel Gene Therapy Based on the Activation of Endogenous Genes for the Treatment of Ischemia - Concepts of endogenetherapy, release of promoter pausing, promoter-targeted ncRNAs and nuclear RNAi

Author(s): Johanna Lähteenvuo, Seppo Ylä-Herttuala
Published in: Human Gene Therapy, Issue 28/11, 2017, Page(s) 1024-1032, ISSN 1043-0342
DOI: 10.1089/hum.2017.129

Published in: ISSN 1523-0864
DOI: 10.1089/ars.2017.7248

Author(s): Johanna P. Laakkonen, Jari P. Lappalainen, Thomas L. Theelen, Pyry I. Toivanen, Tiina Nieminen, Suvi Jauhiainen, Minna U. Kaikkonen, Judith C. Sluimer, Seppo Ylä-Herttuala
Published in: Angiogenesis, Issue 20/1, 2017, Page(s) 109-124, ISSN 0969-6970
DOI: 10.1007/s10456-016-9532-7

Author(s): Iiro Hassinen, Antti Kivelä, Antti Hedman, Antti Saraste, Juhani Knuuti, Juha Hartikainen, Seppo Ylä-Herttuala
Published in: Human Gene Therapy, Issue 27/10, 2016, Page(s) 830-834, ISSN 1043-0342
DOI: 10.1089/hum.2016.131

Author(s): Jussi Nurro, Paavo J Halonen, Antti Kuivanen, Miikka Tarkia, Antti Saraste, Krista Honkonen, Johanna Lähteenvuo, Tuomas T Rissanen, Juhani Knuuti, Seppo Ylä-Herttuala
Published in: Heart, Issue 102/21, 2016, Page(s) 1716-1720, ISSN 1355-6037
DOI: 10.1136/heartjnl-2016-309373

Author(s): Henri Niskanen, Irina Tuszynska, Rafal Zaborowski, Merja Heinäniemi, Seppo Ylä-Herttuala, Bartek Wilczynski, Minna U Kaikkonen
Published in: Nucleic Acids Research, Issue 46/4, 2017, Page(s) 1724-1740, ISSN 0305-1048
DOI: 10.1093/nar/gkx1214

Published in: ISSN 1942-3268
DOI: 10.1161/CIRCGENETICS.117.001702

Author(s): Seppo Ylä-Herttuala, Andrew H. Baker
Published in: Molecular Therapy, Issue 25/5, 2017, Page(s) 1095-1106, ISSN 1525-0016
DOI: 10.1016/j.ymthe.2017.03.027